Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $139 - $180
9 New
9 $0
Q2 2022

Aug 08, 2022

SELL
$14.22 - $20.88 $241 - $354
-17 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$17.2 - $22.5 $292 - $382
17 New
17 $0
Q4 2020

Feb 09, 2021

SELL
$17.83 - $22.29 $7,060 - $8,826
-396 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$15.78 - $20.82 $36,783 - $48,531
-2,331 Reduced 85.48%
396 $8,000
Q2 2020

Aug 11, 2020

SELL
$15.49 - $23.51 $9,836 - $14,928
-635 Reduced 18.89%
2,727 $47,000
Q1 2020

May 15, 2020

SELL
$13.89 - $25.45 $10,334 - $18,934
-744 Reduced 18.12%
3,362 $54,000
Q4 2019

Feb 13, 2020

SELL
$10.7 - $22.24 $46,962 - $97,611
-4,389 Reduced 51.67%
4,106 $85,000
Q3 2019

Oct 17, 2019

BUY
$10.16 - $13.28 $80,142 - $104,752
7,888 Added 1299.51%
8,495 $97,000
Q2 2019

Aug 05, 2019

SELL
$10.62 - $16.59 $18,170 - $28,385
-1,711 Reduced 73.81%
607 $8,000
Q1 2019

Apr 16, 2019

SELL
$13.58 - $18.72 $18,387 - $25,346
-1,354 Reduced 36.87%
2,318 $34,000
Q4 2018

Jan 17, 2019

BUY
$14.78 - $19.68 $46,985 - $62,562
3,179 Added 644.83%
3,672 $62,000
Q3 2018

Nov 02, 2018

SELL
$14.16 - $24.3 $40,894 - $70,178
-2,888 Reduced 85.42%
493 $0
Q2 2018

Jul 24, 2018

BUY
$21.79 - $28.29 $72,538 - $94,177
3,329 Added 6401.92%
3,381 $0
Q1 2018

May 03, 2018

BUY
$18.15 - $29.21 $36 - $58
2 Added 4.0%
52 $1,000
Q4 2017

Feb 02, 2018

BUY
$9.3 - $19.14 $465 - $957
50
50 $1,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.